Jing Ma
Director/Board Member chez NEW CENTURY HEALTHCARE HOLDING CO. LIMITED
Profil
Jing Ma is an Independent Non-Executive Director at New Century Healthcare Holding Co., Ltd.
and a Member at American Association for Cancer Research.
She is also an Associate Professor at Harvard Medical School and Harvard T.H.
Chan School of Public Health.
Dr. Ma holds a doctorate degree from the University of Minnesota, a graduate degree from Tongji Medical College of Huazhong University of Sci & Tech, and an undergraduate degree from Tongji Medical College of Huazhong University of Sci & Tech.
Postes actifs de Jing Ma
Sociétés | Poste | Début |
---|---|---|
NEW CENTURY HEALTHCARE HOLDING CO. LIMITED | Director/Board Member | 22/12/2016 |
Harvard T.H. Chan School of Public Health | Corporate Officer/Principal | 01/01/2012 |
Harvard Medical School | Corporate Officer/Principal | 01/01/2005 |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
Formation de Jing Ma
University of Minnesota | Doctorate Degree |
Tongji Medical College of Huazhong University of Sci & Tech | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
NEW CENTURY HEALTHCARE HOLDING CO. LIMITED | Health Services |
Entreprise privées | 1 |
---|---|
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |